Purchase Order HHSN275201700067P
- Not listed
- This is a firm fixed-price purchase order awarded by the National Institute of Mental Health (NIMH), a civilian federal agency, to Life Molecular Imaging LIMITED, a UK-based for-profit manufacturer of radiopharmaceuticals and molecular imaging technologies. The $84,400 contract is for the provision of an amyloid imaging agent, which supports critical medical research, specifically the Baltimore Longitudinal Study of Aging. The contract has no set-aside designation. Life Molecular Imaging LIMITED...
- This is a firm fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency, to Life Molecular Imaging LIMITED, a for-profit manufacturer of goods headquartered in the United Kingdom. The purpose of the $60,000.00 contract is for Life Molecular Imaging LIMITED to provide 40 FDA-approved amyloid positron emission tomography (PET) radioligand doses. The delivery order is part of a larger $1,900,000.00 indefinite delivery vehicle (IDV) contract Life...
- This is a firm fixed-price federal contract award to Life Molecular Imaging LIMITED, a for-profit organization and manufacturer of goods based in the United Kingdom. The contract, valued at $16,800.00, was awarded by the National Institute of Child Health and Human Development (NICHD) on August 19, 2016 and has an ultimate completion date of December 31, 2016. The contract is for the provision of Florbetaben F18 Injections, which are radiopharmaceuticals used for positron emission tomography...
- The Department of Health and Human Services' National Institutes of Health National Institute on Aging awarded a $60,000 firm fixed price delivery order contract to Life Molecular Imaging Limited for amyloid doses. Under this contract, Life Molecular Imaging Limited will provide amyloid doses to support the National Institute on Aging's research efforts. The contract has a period of performance of one year, running from September 15, 2023 through September 14, 2024. Life Molecular Imaging...
- The National Institutes of Health's National Institute of Child Health and Human Development awarded a $24,000 purchase order contract to Life Molecular Imaging Limited of Great Britain for drugs and biologicals. The firm fixed price contract runs from April 18, 2016 through September 30, 2016 to deliver pharmaceutical products in support of NIH/NICHD research initiatives. No major subcontractors or set aside designations were identified. Life Molecular Imaging Limited will provide the requested...
- This is a single award indefinite delivery contract with a ceiling value of $43,900.00 awarded by the National Institute on Aging (NIA), a component of the U.S. Department of Health and Human Services (HHS), to Life Molecular Imaging Limited. The contract is for the delivery of FDA-approved amyloid and tau protein positron emission tomography (PET) radioligand doses to support the NIA's Baltimore Longitudinal Study of Aging, which aims to characterize longitudinal brain changes through molecular...
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $86,000 delivery order contract to Life Molecular Imaging LIMITED for PI-2620 TAU imaging services. Under the terms of the firm fixed price contract, Life Molecular Imaging LIMITED, operating out of Sterling, Virginia, will provide positron emission tomography imaging of tau protein deposits in the brain to support the National Institute on Aging's research efforts. The one-year...
- The National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $90,000.00 firm fixed price delivery order to Life Molecular Imaging Limited, a global leader in radiopharmaceuticals. The contract is to provide amyloid doses and tau protein positron emission tomography (PET) imaging services to support NIA's research efforts and mission of understanding aging and extending healthy lifespans. This award is part of a larger $1.9 million...
- The National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health, has awarded a firm fixed-price delivery order contract to Chesapeake Open MRI, LLC (doing business as Chesapeake Medical Imaging), a for-profit limited liability company. The $151,400.00 contract is for the delivery of specialized positron emission tomography (PET) radiotracer doses to support amyloid and tau imaging research in the Baltimore Longitudinal Study of Aging. This contract is part...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Mediso USA, LLC for a preventative maintenance and service agreement for a Mediso MultiScan LFER 150 PET/CT imaging system. The contract has a period of performance from May 17, 2023 to May 16, 2024, with a total ceiling value of $339,825.00 over the full five-year potential...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD) to Life Molecular Imaging LIMITED, a UK-based manufacturer of radiopharmaceuticals and molecular imaging technologies. The $12,000 contract is for the delivery of FDA-approved radioligand doses to support medical research, specifically the Baltimore Longitudinal Study of Aging, which aims to characterize brain changes and understand aging processes. Life Molecular Imaging LIMITED has previously received federal contract awards from agencies like the National Institute on Aging (NIA) and the National Institute of Mental Health (NIMH) for similar specialized imaging services and radioligand doses, ranging from $43,900 to $90,000. This contract is not associated with a set-aside designation and does not appear to be part of a larger indefinite delivery vehicle (IDV). However, the company does hold a separate $1,900,000 IDV with the NIA focused on acquiring amyloid and tau PET radioligand doses to measure brain pathology in support of the agency's research goals.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | ($2k) | 2/4/22 | |
| 1 | Other Administrative Action | ($600) | 12/2/16 | |
| Not listed | Not listed | $15.0k | 11/22/16 |